Alzheimer’s Disease “Non-amyloidogenic” p3 Peptide Revisited: A Case for Amyloid-α-Reference-Cited by-同舟云学术

Alzheimer’s Disease “Non-amyloidogenic” p3 Peptide Revisited: A Case for Amyloid-α

Published:2020-05-15 Issue:11 Volume:11 Page:1539-1544
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Kuhn Ariel J.¹,Abrams Benjamin S.²,Knowlton Stella¹,Raskatov Jevgenij A.¹^ORCID

Affiliation:

1. Department of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, California 95064, United States

2. Department of Biomolecular Engineering, Life Sciences Microscopy Center, University of California, Santa Cruz, Santa Cruz, California 95064, United States

Funder

National Institute on Aging

University of California, Santa Cruz

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00160

Reference58 articles.

1. Prince, M., Wilmo, A., Guerchet, M., Ali, G.C., Wu, Y.T., and Prina, M. (2015) World Alzheimer Report 2015: The Global Impact of Dementia.

2. Proteomic Characterization of Postmortem Amyloid Plaques Isolated by Laser Capture Microdissection

3. Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease

4. Alzheimer's disease drug development pipeline: 2018

5. Lowering of Amyloid-Beta by β-Secretase Inhibitors — Some Informative Failures

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: an update of the literature;Expert Review of Neurotherapeutics;2024-09-04

2. Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling;eLife;2024-07-19

3. Advanced nanoparticle strategies for optimizing RNA therapeutic delivery in neurodegenerative disorders;Biomedicine & Pharmacotherapy;2024-06

4. Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling;2024-05-30

5. Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-04-16